[Vaccination against human papillomavirus]

Area of Science:

• Public Health
• Vaccinology
• Oncology

Background:

• Human papillomavirus (HPV) infections are a major cause of several cancers.
• The German Standing Committee on Vaccination (STIKO) recommends HPV vaccination for adolescents.
• Current HPV immunization coverage in Germany is suboptimal, ranging from 45-60%.

Purpose of the Study:

• To highlight the efficacy and safety of HPV vaccination.
• To emphasize the importance of increasing HPV immunization rates in Germany.
• To support the WHO's global initiative for cervical cancer elimination.

Main Methods:

• This abstract is based on current recommendations and established scientific evidence regarding HPV vaccination.
• It synthesizes data on vaccine effectiveness and public health impact.

Main Results:

• HPV vaccination is highly effective and safe.
• Vaccination before first sexual intercourse can prevent up to 90% of cervical cancers and precancerous lesions.
• The vaccine also prevents HPV-associated cancers of the vulva, vagina, anus, penis, and oropharynx.

Conclusions:

• Achieving high HPV immunization coverage is crucial for public health.
• Eliminating cervical cancer and reducing other HPV-associated cancers are achievable goals with increased vaccination rates.
• The long-term effects and immunogenicity of the HPV vaccine support its role in cancer prevention.